sutab

Generic: sodium sulfate, magnesium sulfate, and potassium chloride

Labeler: braintree laboratories, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name sutab
Generic Name sodium sulfate, magnesium sulfate, and potassium chloride
Labeler braintree laboratories, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

magnesium sulfate anhydrous 2.7 g/1, potassium chloride 2.25 g/1, sodium sulfate 17.75 g/1

Manufacturer
Braintree Laboratories, Inc.

Identifiers & Regulatory

Product NDC 52268-201
Product ID 52268-201_093f5259-d407-4295-e063-6294a90abb17
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA213135
Listing Expiration 2026-12-31
Marketing Start 2020-11-10

Pharmacologic Class

Classes
calculi dissolution agent [epc] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52268201
Hyphenated Format 52268-201

Supplemental Identifiers

UNII
ML30MJ2U7I 660YQ98I10 0YPR65R21J

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sutab (source: ndc)
Generic Name sodium sulfate, magnesium sulfate, and potassium chloride (source: ndc)
Application Number NDA213135 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.7 g/1
  • 2.25 g/1
  • 17.75 g/1
source: ndc
Packaging
  • 2 BOTTLE, PLASTIC in 1 KIT (52268-201-01) / 12 TABLET in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

Ingredients (3)

magnesium sulfate anhydrous (2.7 g/1) potassium chloride (2.25 g/1) sodium sulfate (17.75 g/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "093f5259-d407-4295-e063-6294a90abb17", "openfda": {"unii": ["ML30MJ2U7I", "660YQ98I10", "0YPR65R21J"], "spl_set_id": ["dddd2701-4d46-44de-a9f8-303d4dcceef7"], "manufacturer_name": ["Braintree Laboratories, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BOTTLE, PLASTIC in 1 KIT (52268-201-01)  / 12 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "52268-201-01", "marketing_start_date": "20201110"}], "brand_name": "SUTAB", "product_id": "52268-201_093f5259-d407-4295-e063-6294a90abb17", "dosage_form": "TABLET", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "52268-201", "generic_name": "sodium sulfate, magnesium sulfate, and potassium chloride", "labeler_name": "Braintree Laboratories, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SUTAB", "active_ingredients": [{"name": "MAGNESIUM SULFATE ANHYDROUS", "strength": "2.7 g/1"}, {"name": "POTASSIUM CHLORIDE", "strength": "2.25 g/1"}, {"name": "SODIUM SULFATE", "strength": "17.75 g/1"}], "application_number": "NDA213135", "marketing_category": "NDA", "marketing_start_date": "20201110", "listing_expiration_date": "20261231"}